Circulating levels of these mediators, together with CRP, constitute relevant damage biomarkers connecting chronic metabolic diseases such as obesity and T2D with incident dementia or late-onset AD (Franceschi and Campisi, 2014). The gene discussed is CRP; the disease is type 2 diabetes mellitus.